BioNTech SE BNTX
NASDAQ BNTX
$103.76 +0.88 (+0.86%)
As of: Sep 4, 2026 · 3:59 PM EDT

BioNTech SE (BNTX) Retained Earnings (2018 - 2026)

BioNTech SE (BNTX) posted Retained Earnings of $20.9 billion for Q4 2025, up 1305.75% sequentially from -$1.7 billion in Q3 2025, and up 2.45% YoY from $20.4 billion in Q4 2024.

Analysis

BioNTech SE (BNTX) Retained Earnings (2018 - 2026) Analysis & Trends

BioNTech SE has reported Retained Earnings for 8 years, with the latest figure at $20.9 billion in Q4 2025.

  • Quarterly Retained Earnings rose 2.45% year-over-year to $20.9 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $20.9 billion (up 2.45% YoY) and the FY2025 annual result came in at $20.3 billion, down 0.56% from the prior year.
  • Retained Earnings grew to $20.9 billion in Q4 2025 per BNTX's latest filing, from -$1.7 billion in the prior quarter.
  • Over five years, Retained Earnings peaked at $20.9 billion in Q4 2025 and troughed at -$1.7 billion in Q3 2025.
  • A 5-year average of $1.6 billion and a median of -$952.3 million in 2023 frame the typical range for Retained Earnings.
  • The sharpest annual moves came in 2022 and 2024: Retained Earnings plunged 906.27% in 2022, then jumped 2026.43% in 2024.
  • Over 5 years, Retained Earnings stood at $107.4 million in 2021, then slumped by 906.27% to -$866.1 million in 2022, then fell by 22.32% to -$1.1 billion in 2023, then soared by 2026.43% to $20.4 billion in 2024, then climbed by 2.45% to $20.9 billion in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods registered $20.9 billion, -$1.7 billion, and -$1.7 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 BioNTech SE 25.06 Bn 11.41 Bn 10.00 Mn 19.31 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.31 Bn
Mar 31, 2026 20.41 Bn
Dec 31, 2025 20.91 Bn
Sep 30, 2025 21.36 Bn
Jun 30, 2025 20.71 Bn
Mar 31, 2025 19.65 Bn
Dec 31, 2024 20.41 Bn
Sep 30, 2024 20.69 Bn
Jun 30, 2024 20.07 Bn
Mar 31, 2024 21.13 Bn
Dec 31, 2023 21.26 Bn
Sep 30, 2023 21.02 Bn
Jun 30, 2023 20.85 Bn
Mar 31, 2023 20.75 Bn
Dec 31, 2022 19.21 Bn
Sep 30, 2022 16.69 Bn
Jun 30, 2022 15.76 Bn
Mar 31, 2022 15.24 Bn
Dec 31, 2021 11.31 Bn
Sep 30, 2021 7.92 Bn